Multiple Sclerosis News Today Forums Forums Treating MS MS Medications Mavenclad approved for RRMS and SPMS in US. Would you use it?

  • Mavenclad approved for RRMS and SPMS in US. Would you use it?

    Posted by ed-tobias on March 29, 2019 at 8:13 pm

    Mavenclad (cladribine) has been approved in the US to treat patients with RRMS and active SPMS. This is an oral medication that’s taken for 10 days one year and 10 days the following year. Treatment with Mavenclad then ends.

    There is a warning on the medication’s label that its use may increase the risk of malignancy and fetal harm.

    Is Mavenclad a medication that you would consider using?

    ed-tobias replied 5 years ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.